CN102791207B - Make the calcified material in cardiac valve broken - Google Patents
Make the calcified material in cardiac valve broken Download PDFInfo
- Publication number
- CN102791207B CN102791207B CN201080062697.5A CN201080062697A CN102791207B CN 102791207 B CN102791207 B CN 102791207B CN 201080062697 A CN201080062697 A CN 201080062697A CN 102791207 B CN102791207 B CN 102791207B
- Authority
- CN
- China
- Prior art keywords
- stabilizer
- impactor
- arm
- shaft
- catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22031—Gripping instruments, e.g. forceps, for removing or smashing calculi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00535—Surgical instruments, devices or methods pneumatically or hydraulically operated
- A61B2017/00544—Surgical instruments, devices or methods pneumatically or hydraulically operated pneumatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22069—Immobilising; Stabilising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22098—Decalcification of valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Surgical Instruments (AREA)
- Prostheses (AREA)
Abstract
Description
技术领域 technical field
本发明总体上涉及使心脏瓣膜诸如主动脉瓣膜瓣叶中的钙化物破碎的器件和方法。The present invention generally relates to devices and methods for disrupting calcifications in leaflets of heart valves, such as aortic valves.
背景技术 Background technique
对正常心脏功能必要的是四个心脏瓣膜,该四个心脏瓣膜使得血液能够沿正确流动方向穿过心脏的四个心腔。瓣膜具有两个或三个尖瓣、瓣、或瓣叶,其包括附连到心脏的壁的纤维状组织。当血液流动正确地流动时尖瓣打开并然后关闭以形成紧密密封来防止回流。Essential to normal heart function are four heart valves that allow blood to flow in the correct direction through the four chambers of the heart. Valves have two or three cusps, valves, or leaflets, which consist of fibrous tissue attached to the wall of the heart. The cusps open when blood flow is flowing properly and then close to form a tight seal to prevent backflow.
四个心腔已知为右心房和左心房(上心腔)和右心室和左心室(下心腔)。控制血液流动的四个瓣膜已知为三尖瓣、二尖瓣、肺瓣膜以及主动脉瓣膜。在功能正常的心脏中,三尖瓣允许去氧血液从右上心腔(右心房)到右下心腔(右心室)单向流动。当右心室收缩时,肺瓣膜允许血液从右心室流到肺动脉,则将去氧血液传送到肺。二尖瓣允许已经返回到左上心腔(左心房)的充氧血液流到左下心腔(左心室)。当左心室收缩时,充氧血液通过主动脉瓣膜泵送到主动脉。The four chambers of the heart are known as the right and left atria (upper chambers) and the right and left ventricles (lower chambers). The four valves that control blood flow are known as the tricuspid, mitral, pulmonary, and aortic valves. In a properly functioning heart, the tricuspid valve allows deoxygenated blood to flow in one direction from the upper right heart chamber (right atrium) to the right lower chamber (right ventricle). When the right ventricle contracts, the pulmonary valves allow blood to flow from the right ventricle to the pulmonary artery, which delivers deoxygenated blood to the lungs. The mitral valve allows oxygenated blood that has returned to the upper left chamber of the heart (left atrium) to flow to the lower left chamber of the heart (left ventricle). When the left ventricle contracts, oxygenated blood is pumped through the aortic valve into the aorta.
某些心脏异常源自心脏瓣膜缺陷,诸如狭窄或钙化物。这涉及瓣膜中的钙累积,其阻碍了正常的瓣膜瓣叶移动。Certain heart abnormalities arise from defects in heart valves, such as narrowing or calcifications. This involves calcium buildup in the valve, which hinders the normal movement of the valve leaflets.
发明内容 Contents of the invention
本发明寻求提供可用于使主动脉瓣膜瓣叶中的钙化物破碎的改善的器件和方法,以提高瓣叶的柔软性和机动性,不论用作单独治疗、搭桥治疗或用于经导管瓣膜植入的“着陆区域”的准备。The present invention seeks to provide improved devices and methods that can be used to disrupt calcifications in aortic valve leaflets to increase leaflet softness and mobility, whether as monotherapy, bypass therapy, or for transcatheter valve implantation. Entry into the "landing zone" preparation.
术语“破碎”指尺寸上任何类型的减小或形状或形式的任何改变,诸如但不限于破碎、粉碎、破裂、研磨、截断等。The term "crushing" refers to any type of reduction in size or any change in shape or form, such as, but not limited to, crushing, pulverizing, cracking, grinding, chopping, and the like.
根据本发明的实施例提供了一种用于使心脏瓣膜中的钙化物破碎的器件,包括导管,导管包括其中设置可扩张稳定器的外轴、其上安装可扩张臂的冲击器轴以及内轴,其特征在于,内轴能够移动以致使冲击器臂向外扩张并被锁定在扩张形状,且其中冲击元件能够移动以用足够的能量致使在扩张形状中的冲击器臂朝向组织移动,从而使位于由稳定器固定在与冲击器臂相面对的特定位置中的组织中的钙化物破碎。According to an embodiment of the present invention there is provided a device for fracturing calcifications in a heart valve, comprising a catheter comprising an outer shaft in which an expandable stabilizer is disposed, an impactor shaft on which an expandable arm is mounted, and an inner shaft, wherein the inner shaft is movable to cause the impactor arms to expand outward and locked in the expanded shape, and wherein the impact element is movable to cause the impactor arms in the expanded shape to move toward the tissue with sufficient energy to thereby Calcifications located in the tissue held by the stabilizer in a specific position facing the impactor arm are broken up.
根据本发明的非限制性实施例,该冲击元件包括内轴,内轴连接到冲击器臂的远侧部并可操作以相对于冲击器轴移动以使冲击器臂向外扩张并用足够的能量致使在扩张形状中的冲击器臂朝向稳定器移动。内轴可以相对于冲击器轴锁定,从而固定冲击器臂。According to a non-limiting embodiment of the present invention, the impact element includes an inner shaft connected to the distal portion of the impactor arm and operable to move relative to the impactor shaft to expand the impactor arm outward and apply sufficient energy The impactor arm in the expanded configuration is caused to move towards the stabilizer. The inner shaft can be locked relative to the striker shaft, thereby securing the striker arm.
根据本发明的非限制性实施例,冲击元件包括重物和偏压器件,其中,偏压器件用足够的能量将该重物朝向冲击器臂推压。一个示例中,该重物安装在偏压器件上,该偏压器件固定到导管的远侧末端。另一示例中,该重物固定到导管的内轴。又一示例中,该偏压器件包括连接到加压气源的气动能量源。According to a non-limiting embodiment of the invention, the impact element comprises a weight and biasing means, wherein the biasing means urges the weight towards the impactor arm with sufficient energy. In one example, the weight is mounted on a biasing device secured to the distal tip of the catheter. In another example, the weight is fixed to the inner shaft of the catheter. In yet another example, the biasing device includes a source of pneumatic energy connected to a source of pressurized gas.
根据本发明的非限制性实施例,稳定器包括稳定器结构,该稳定器结构包括可选地由稳定器盖覆盖的一个或更多个(具有任何形式或形状,诸如杆、环、或更复杂的结构的)元件。稳定器可包括由覆盖气囊覆盖的稳定器结构。充气/放气管可被插入覆盖气囊中。第一压力传感器可靠近稳定器定位(在导管的位于主动脉的部分中),而第二压力传感器可靠近冲击器臂定位(在导管的位于LVOT或左心室的部分中)。对于跨顶使用,该器件可以“相反”方式设计,从而冲击器是近侧而稳定器可以定位在器件的远侧末端处。稳定器臂可以从外轴向外扩张。According to a non-limiting embodiment of the invention, the stabilizer comprises a stabilizer structure comprising one or more (of any form or shape, such as a rod, ring, or more) optionally covered by a stabilizer cover. components of complex structures). The stabilizer may include a stabilizer structure covered by a covering bladder. An inflation/deflation tube can be inserted into the cover bladder. A first pressure sensor may be positioned near the stabilizer (in the portion of the catheter located in the aorta), while a second pressure sensor may be located near the impactor arm (in the portion of the catheter located in the LVOT or left ventricle). For cross-top use, the device can be designed in a "reverse" fashion, so that the impactor is proximal and the stabilizer can be positioned at the distal end of the device. The stabilizer arms can expand outward from the outer shaft.
附图说明 Description of drawings
从结合附图的以下详细描述将更完全地理解和认识到本发明,在附图中:The present invention will be more fully understood and appreciated from the following detailed description taken in conjunction with the accompanying drawings, in which:
图1是钙化主动脉、升主动脉和主动脉弓的解剖体的简化说明。Figure 1 is a simplified illustration of the anatomy of the calcified aorta, ascending aorta, and aortic arch.
图2是钙化的主动脉瓣膜的放大图。Figure 2 is an enlarged view of a calcified aortic valve.
图3是根据本发明的非限制实施例构造和运行的可用于使主动脉瓣膜钙化物破碎的冲击器导管系统的远侧部的简化说明。3 is a simplified illustration of the distal portion of an impactor catheter system that may be used to disrupt aortic valve calcifications, constructed and operative in accordance with a non-limiting embodiment of the present invention.
图4是在图3的导管的近侧处出来的若干轴的简化说明。FIG. 4 is a simplified illustration of several shafts coming out proximally of the catheter of FIG. 3 .
图5是根据本发明的另一非限制实施例的采用重物的使心脏瓣膜中的钙化物破碎的器件。Figure 5 is a device for breaking up calcifications in a heart valve using a weight according to another non-limiting embodiment of the present invention.
图5A和5B分别是重物在冲击之前和冲击之后的简化说明。5A and 5B are simplified illustrations of a weight before impact and after impact, respectively.
图6和6A是根据本发明的又一非限制实施例的通过重物使心脏瓣膜中的钙化物破碎的器件的简化说明。6 and 6A are simplified illustrations of a device for breaking up calcifications in a heart valve with a weight, according to yet another non-limiting embodiment of the present invention.
图7-10C是根据本发明的不同的非限制实施例的若干类型的稳定器的简化说明,这些稳定器可用于有效地定位器件的远侧部、在冲击期间将瓣叶的一部分保持到位以及反作用于被施加到瓣膜瓣叶的心室方面的冲击。7-10C are simplified illustrations of several types of stabilizers that can be used to effectively position the distal portion of the device, hold a portion of the leaflet in place during impact, and Reacts to the ventricular impact applied to the valve leaflets.
图11是根据本发明的非限制实施例的具有不止一个面对每个瓣叶的臂的冲击器臂的简化说明。11 is a simplified illustration of an impactor arm having more than one arm facing each leaflet, according to a non-limiting embodiment of the invention.
图12是根据本发明的非限制实施例的冲击器导管的简化说明,其在手术期间最优地保持瓣膜功能,同时允许左心室与主动脉之间血液压力梯度的连续测量。12 is a simplified illustration of an impactor catheter that optimally preserves valve function during surgery while allowing continuous measurement of the blood pressure gradient between the left ventricle and the aorta, according to a non-limiting embodiment of the present invention.
图13是根据本发明的非限制实施例的将冲击递送到钙化的瓣膜瓣叶的器件的跨顶构造的简化说明。13 is a simplified illustration of a transapical configuration of a device for delivering shocks to calcified valve leaflets, according to a non-limiting embodiment of the invention.
图14和图15是根据本发明的非限制实施例的基于导管的近侧上的气动能量源和远侧部上的重物牵引冲击机构的冲击器导管的简化说明。14 and 15 are simplified illustrations of impactor catheters based on a pneumatic energy source on the proximal side of the catheter and a weight pull impact mechanism on the distal portion, according to a non-limiting embodiment of the invention.
图16A-16D是根据本发明的另一非限制实施例构造和运行的冲击器器件的简化说明。16A-16D are simplified illustrations of an impactor device constructed and operative in accordance with another non-limiting embodiment of the present invention.
图17是图16A-16D的器件的远端的简化说明,示出在打开状态下的定位和振动元件。Figure 17 is a simplified illustration of the distal end of the device of Figures 16A-16D showing the positioning and vibrating elements in an open state.
图18A和18B是有疾病的三尖瓣心脏瓣膜,其中有疾病的瓣叶具有钙化病变。18A and 18B are diseased tricuspid heart valves in which the diseased leaflets have calcified lesions.
图19A-19I是根据本发明的另一非限制实施例的使用图16A-16D的器件的方法的简化说明。19A-19I are simplified illustrations of a method of using the device of FIGS. 16A-16D according to another non-limiting embodiment of the invention.
图20是器件的定位元件的简化说明,该器件具有与之相连的网以捕获可能产生的作为处理的一部分的任何碎片。Figure 20 is a simplified illustration of the positioning elements of the device with a net attached thereto to capture any debris that may be generated as part of the process.
图21A和21B是另一实施例的简化说明,其中,定位元件是可充气的垫或气囊。21A and 21B are simplified illustrations of another embodiment in which the positioning element is an inflatable pad or bladder.
图22A示出了穿过主动脉壁的纵向剖切图,其中由冲击器在瓣叶的中心线处形成破碎线。Figure 22A shows a longitudinal section through the aortic wall with a fracture line created by the impactor at the centerline of the leaflet.
图22B是典型瓣叶在靠近其中心线产生单次破碎之后的X光照片。Figure 22B is a radiograph of a typical valve leaflet after a single fragmentation near its centerline.
具体实施方式 Detailed ways
现参考图1,图1示出钙化的主动脉瓣膜、升主动脉以及主动脉弓的解剖体。钙化物可能嵌入在瓣膜瓣叶中,瓣膜瓣叶在冠状动脉开口的正下方连接到主动脉壁。Reference is now made to Figure 1, which illustrates the anatomy of a calcified aortic valve, ascending aorta, and aortic arch. The calcifications may be embedded in the valve leaflets, which attach to the aortic wall just below the coronary opening.
现参考图2,图2是钙化的主动脉瓣膜的放大图。瓣叶在其主动脉方面上在冠状动脉开口正下方形成凹窦。钙化物可嵌入在瓣叶中,使得瓣叶变厚且较不柔软。具体来说,出现在瓣叶基部处的,即出现在瓣叶连接到环带壁或动脉壁的位置处的钙化物可显著地消弱瓣叶的机动性,类似于门铰链的摩擦。Reference is now made to Figure 2, which is an enlarged view of a calcified aortic valve. The valve leaflets form a concave sinus just below the coronary ostia on its aortic aspect. Calcifications can become embedded in the leaflets, making them thicker and less supple. Specifically, calcifications that develop at the base of the leaflets, where they attach to the annulus or artery wall, can significantly impair leaflet mobility, similar to friction on a door hinge.
现参考图3,图3是根据本发明的非限制实施例构造和运行的可用于使主动脉瓣膜钙化破碎的冲击器导管系统的远侧部。Reference is now made to FIG. 3, which is a distal portion of an impactor catheter system useful for disrupting calcified aortic valves, constructed and operative in accordance with a non-limiting embodiment of the present invention.
导管10可使用逆行方法通过引线11递送穿过诸如周围动脉的血管,穿过主动脉弓并进入位于主动脉瓣膜正上方的升主动脉。在该阶段,所有的导管部件仍由导管外轴12覆盖。然后收回外轴12,从而连接到稳定器轴16的可扩张(例如自扩张)稳定器14打开。稳定器14用于将导管远侧部引导、定位并锚固在窦中在瓣膜瓣叶的正上方。注意,导管10仅仅是用于递送和操作下面描述的稳定器和用于冲击钙化物的冲击器臂的递送系统的一个示例。可选地,下面描述的稳定器和冲击器臂可通过除了导管之外的其它器件来递送和/或操作,诸如引线或引线和推/拉线系统。Catheter 10 may be delivered through a guide wire 11 using a retrograde approach through a blood vessel, such as a peripheral artery, through the aortic arch and into the ascending aorta just above the aortic valve. At this stage, all catheter components are still covered by the outer catheter shaft 12 . The outer shaft 12 is then retracted, thereby opening the expandable (eg, self-expanding) stabilizer 14 connected to the stabilizer shaft 16 . The stabilizer 14 is used to guide, position and anchor the distal portion of the catheter in the sinus just above the valve leaflets. Note that catheter 10 is only one example of a delivery system for delivering and operating the stabilizer described below and the impactor arm for impacting calcifications. Alternatively, the stabilizer and impactor arms described below may be delivered and/or operated by means other than catheters, such as leads or lead and push/pull systems.
包括冲击器臂20的冲击器轴18然后被向前(朝向远侧)推过瓣膜的中心进入左心室。当向前推时,冲击器臂20被折叠,从而它们可容易地穿过瓣膜。然后,连接到冲击器臂20的远侧部的内轴22被朝向近侧牵引以致使冲击器臂20侧移向外打开(扩张)并且将它们锁定在扩张形状。然后,冲击器轴18和内轴22回拉(朝向近侧)一点以使得冲击器臂20与瓣叶的心室方面有良好的接触,从而瓣叶被“夹”在近侧定位的稳定器14(从附图上方)与远侧定位的冲击器臂20(从附图下方)之间。为了使瓣叶钙化物破碎,在稳定器14将瓣叶的相关部分保持就位的同时,通过以至少1m/sec(诸如但不限制于约5-20m/sec)的速度但具有至少0.5mm(诸如但不限制于约0.5-3mm)的振幅来牵引冲击器轴18和内轴22,从而朝向瓣叶组织突然地牵引冲击器臂20,从而使钙化物破碎而不伤害软组织。The impactor shaft 18, including the impactor arm 20, is then pushed forward (toward the distal side) through the center of the valve and into the left ventricle. When pushed forward, the impactor arms 20 are folded so that they can easily pass through the valve. The inner shaft 22 connected to the distal portion of the impactor arms 20 is then pulled proximally to cause the impactor arms 20 to move laterally outwardly to open (expand) and lock them in the expanded shape. The impactor shaft 18 and inner shaft 22 are then pulled back (proximally) a little so that the impactor arm 20 makes good contact with the ventricular aspect of the leaflet so that the leaflet is "clamped" against the proximally positioned stabilizer 14 (from above in the figure) and the distally positioned impactor arm 20 (from below in the figure). To break up the leaflet calcifications, while the stabilizer 14 holds the relevant portion of the leaflet in place, the valve is passed at a speed of at least 1 m/sec (such as but not limited to about 5-20 m/sec) but with at least 0.5 mm An amplitude such as, but not limited to, about 0.5-3 mm pulls the impactor shaft 18 and inner shaft 22 to abruptly pull the impactor arm 20 toward the leaflet tissue, breaking up the calcifications without injuring the soft tissue.
现参考图4,图4示出在图3所示的导管10的近侧处出来的多个轴。通过控制这些轴的相对位置来完成导管10的整个操作。例如,如图3所示,内轴22被相对于冲击器轴18牵引以打开冲击器臂20。内轴22和冲击器轴18锁定在一起,从而固定冲击器臂20。为了在导管的远侧部处产生有效的冲击,内轴/冲击器轴22/18在稳定器轴16固定的状态下被相对于瓣膜瓣叶组织突然地一起牵引。该近侧处的突然牵引被传递到远侧部。Reference is now made to FIG. 4 , which shows a plurality of shafts coming out proximally of the catheter 10 shown in FIG. 3 . The overall operation of catheter 10 is accomplished by controlling the relative positions of these shafts. For example, as shown in FIG. 3 , the inner shaft 22 is pulled relative to the striker shaft 18 to open the striker arm 20 . The inner shaft 22 and striker shaft 18 lock together, thereby securing the striker arm 20 . In order to create an effective impact at the distal portion of the catheter, the inner/impactor shaft 22/18 is suddenly drawn together against the valve leaflet tissue with the stabilizer shaft 16 fixed. This sudden pull at the proximal side is transferred to the distal portion.
现参考图5,图5示出用于在导管的远侧部处产生冲击的替代机构。重物24安装在偏压器件26(例如卷簧)上,偏压器件26固定到导管的远侧末端28。在冲击之前(图5A),重物24被推向远侧末端28,从而缩回偏压器件26。为了产生冲击,重物24被释放,从而偏压器件26能够加速重物24,直到重物24击打冲击器臂20(图5B)。冲击器臂20又冲击钙化的瓣叶。为了在给定的加速重物24的特定动量下最大化冲击器臂20的冲击速率,可减小冲击器臂20的质量。这可通过选择亦为弹簧状的冲击器轴18、最小化冲击器轴18的推进性、或者通过使得冲击器臂20“浮动”且在冲击期间相对于导管的其它部分无摩擦地自由移动来部分地实现。Reference is now made to Figure 5, which illustrates an alternative mechanism for generating an impact at the distal portion of the catheter. The weight 24 is mounted on a biasing means 26, such as a coil spring, which is secured to a distal tip 28 of the catheter. Prior to impact ( FIG. 5A ), weight 24 is pushed toward distal tip 28 , thereby retracting biasing device 26 . To generate an impact, the weight 24 is released so that the biasing device 26 can accelerate the weight 24 until the weight 24 strikes the impactor arm 20 (FIG. 5B). The impactor arm 20 in turn impacts the calcified leaflet. In order to maximize the impact velocity of the impactor arm 20 for a given specific momentum of the accelerating weight 24, the mass of the impactor arm 20 may be reduced. This can be done by choosing an impactor shaft 18 that is also spring-like, minimizing the propulsion of the impactor shaft 18, or by allowing the impactor arm 20 to "float" and move freely relative to the rest of the catheter during impact without friction. partially realized.
现参考图6,图6示出用于在导管的远侧部处产生冲击的另一替代机构。重物24A(可以是导管末端)固定到导管的内轴22(该构造中,冲击器臂20不连接到内轴22)。在冲击之前,内轴22被朝向远侧推,从而重物24A移动离开冲击器臂20某一距离(可以是几毫米到几厘米)。为了产生冲击,现在,重物24A被朝向近侧加速直到其以高速击打冲击器臂20。偏压器件26A(图6A中示出其一个版本)、气动机构或任何其它机构可用于产生该质量所要求的加速度。该方法优于图3-4中所描述的方法的优点在于:当能量源是外部的时,可通过使用更强大的偏压器件或能量源来更容易地在导管的远侧部处产生高速率。Reference is now made to Figure 6, which illustrates another alternative mechanism for generating an impact at the distal portion of the catheter. A weight 24A (which may be the end of the catheter) is fixed to the inner shaft 22 of the catheter (in this configuration the impactor arm 20 is not attached to the inner shaft 22). Prior to impact, the inner shaft 22 is pushed distally so that the weight 24A moves a certain distance away from the impactor arm 20 (which may be a few millimeters to a few centimeters). To generate an impact, the weight 24A is now accelerated proximally until it strikes the impactor arm 20 at high speed. A biasing device 26A (a version of which is shown in FIG. 6A ), a pneumatic mechanism, or any other mechanism may be used to generate the required acceleration of the mass. The advantage of this method over that described in FIGS. 3-4 is that when the energy source is external, it is easier to generate a high voltage at the distal portion of the catheter by using a more powerful biasing device or energy source. rate.
现参考图7-10,图7-10示出多种类型稳定器,这些稳定器可用于有效地将导管的远侧部相对于瓣膜解剖体定位、在冲击期间将瓣膜瓣叶的某些部分保持就位以及反作用于施加到瓣膜瓣叶的心室方面的冲击。理想的是在冲击的期间最大化在瓣叶的主动脉方面上的反作用力,同时确保稳定器表面足够柔顺和钝,从而最小化对瓣叶表面的损伤。Reference is now made to FIGS. 7-10, which illustrate various types of stabilizers that can be used to effectively position the distal portion of the catheter relative to the valve anatomy, or position portions of the valve leaflets during impact. Stays in place and reacts to the ventricular impact applied to the valve leaflets. It is desirable to maximize the reaction force on the aortic aspect of the leaflet during impact while ensuring that the stabilizer surface is sufficiently compliant and blunt to minimize damage to the leaflet surface.
现参考图7,图7示出可采取一个或更多个环的形式的稳定器结构30(例如,至少一个环装配入瓣叶上方的每个窦中,对于二尖瓣主动脉瓣膜是两个或更多个,而对于三尖瓣主动脉瓣膜是三个或更多个)。稳定器结构30(可选地)被稳定器盖32覆盖,稳定器盖32可以是薄金属网(网状物)、实心塑料表面等。如果稳定器盖32是实心的,或如果稳定器盖基于具有足够小的孔的网状物,那么稳定器盖32可以用作血栓保护装置,即,在冲击手术结束时,如果产生任何栓塞物,那么在使用外轴折叠稳定器时,这些栓塞物可被安全地收集入导管。Reference is now made to FIG. 7 which shows a stabilizer structure 30 which may take the form of one or more rings (e.g., at least one ring fits into each sinus above the valve leaflets, two for a mitral aortic valve). one or more, and three or more for the tricuspid aortic valve). The stabilizer structure 30 is (optionally) covered by a stabilizer cover 32, which may be a thin metal mesh (mesh), a solid plastic surface, or the like. If the stabilizer cover 32 is solid, or if the stabilizer cover is based on a mesh with sufficiently small pores, the stabilizer cover 32 can be used as an embolic protection device, i.e., at the end of the shock procedure, should any embolic , these emboli can then be safely collected into the catheter when using the external shaft folded stabilizer.
现参考图8,图8示出替代的稳定器设计,其将覆盖气囊34整合在每个稳定器结构30上。每个气囊34是细长的且其中心轴线跟随组成稳定器结构30的环的曲率。环还可以用作气囊的充气/放气管,其中,用于充气的流体经过一个或更多个充气/放气开口36。气囊基稳定器的很大优点是稳定器可以通过将气囊放气而定位在窦中。然后,气囊34能够被充气以产生与瓣叶表面的充分接触,从而最大化冲击反作用力,同时避免损伤。Reference is now made to FIG. 8 , which shows an alternative stabilizer design that integrates a cover bladder 34 on each stabilizer structure 30 . Each bladder 34 is elongated and its central axis follows the curvature of the rings making up the stabilizer structure 30 . The ring may also serve as an inflation/deflation tube for the air bag, wherein fluid for inflation passes through one or more inflation/deflation openings 36 . A great advantage of a balloon-based stabilizer is that the stabilizer can be positioned in the sinus by deflation of the balloon. The balloon 34 can then be inflated to create sufficient contact with the leaflet surface to maximize impact reaction forces while avoiding trauma.
现参考图9,图9示出气囊基稳定器的另一设计。三个覆盖气囊34中的每个覆盖稳定器结构环30中的一个。充气/放气管38可在其近侧被插入每个气囊中。图10A示出气囊34的俯视图。图10B和10C分别示出放气和充气的气囊34的侧视图。Reference is now made to FIG. 9, which shows another design of an airbag-based stabilizer. Each of the three covering bladders 34 covers one of the stabilizer structural rings 30 . An inflation/deflation tube 38 may be inserted into each balloon proximally thereof. FIG. 10A shows a top view of the airbag 34 . 10B and 10C show side views of the deflated and inflated balloon 34, respectively.
现参考图11,图11示出冲击器臂20的另一构造,其包括多个面向每个瓣膜的臂。可容易地理解,冲击器臂的数目和几何形状是基于人们所希望冲击的瓣叶的最优位置的,例如每个瓣叶的冲击线、点或区域的数目和取向,更靠近瓣叶基部或末端的冲击等。Reference is now made to Fig. 11, which shows another configuration of impactor arm 20 comprising a plurality of arms facing each valve. It is readily understood that the number and geometry of the impactor arms is based on the optimal location of the leaflets one wishes to impact, such as the number and orientation of impact lines, points or areas per leaflet, closer to the leaflet base Or the impact of the end, etc.
现参考图12,图12示出冲击器导管的构造,其在手术期间最优地保持瓣膜功能,同时允许左心室与动脉之间的血压梯度的连续测量。冲击器臂20和稳定器结构30仅在瓣叶的基部处接触瓣叶,即环带附近,这里严重钙化的瓣叶通常是不可移动的。瓣叶末端保持自由移动,从而在器件递送冲击时,全部瓣膜功能几乎不受器件的干扰。两个压力传感器,即在瓣膜上方(靠近稳定器)的第一压力传感器40和在瓣膜下方(靠近冲击器臂)的第二压力传感器42分别测量动脉和心室的血压。这允许对穿过瓣膜的压力梯度的连续测量,这可用作对于手术的成功来说非常重要的实时反馈。除了在器件中整合压力传感器之外,人们可设计在导管中的足够大的管道,该管道具有在需要测量压力的每个所关心的区域处的远侧开口和可连接到患者身体外部的压力传感器的近侧端口。Reference is now made to Figure 12, which illustrates the configuration of an impactor catheter that optimally preserves valve function during surgery while allowing continuous measurement of the blood pressure gradient between the left ventricle and the artery. The impactor arm 20 and stabilizer structure 30 contact the leaflet only at its base, ie near the annulus, where heavily calcified leaflets are usually immobile. The leaflet tips remain free to move so that overall valve function is little disturbed by the device as the device delivers shocks. Two pressure sensors, a first pressure sensor 40 above the valve (closer to the stabilizer) and a second pressure sensor 42 below the valve (closer to the impactor arm), measure arterial and ventricular blood pressure, respectively. This allows continuous measurement of the pressure gradient across the valve, which can be used as real-time feedback that is very important to the success of the procedure. In addition to integrating pressure sensors in the device, one can design a sufficiently large tubing in the catheter with a distal opening at each region of interest where pressure needs to be measured and can be connected to a pressure sensor outside the patient's body. Proximal port of the sensor.
现参考图13,图13示出将冲击递送到钙化的瓣膜瓣叶的器件的跨顶(trans-apical)构造。类似的元件与上面类似地标记。跨顶方法虽然比经股方法更具有侵略性,但跨顶方法允许该器件是刚性的且是短的,由此潜在地改善冲击从器件的近侧部(外部)到其远侧部上的冲击器臂的递送。稳定器14更靠近器件的远侧末端44定位。末端44必须首先穿过瓣膜并打开稳定器14以定位器件、保持瓣叶的某些部分并反作用于冲击。Reference is now made to Figure 13, which illustrates a trans-apical configuration of a device for delivering shocks to calcified valve leaflets. Similar elements are labeled similarly as above. The transapical approach, although more aggressive than the transfemoral approach, allows the device to be rigid and short, thereby potentially improving impact from the proximal (outer) portion of the device to its distal portion. Delivery of the impactor arm. The stabilizer 14 is positioned closer to the distal tip 44 of the device. The tip 44 must first pass through the valve and open the stabilizer 14 to position the device, hold some portion of the leaflet and react to the impact.
现参考图14和图15,图14和图15示出基于导管的近侧上的气动能量源和远侧部上的重物牵引冲击机构的冲击器导管的一个实施例。再次,类似的元件与上面类似地标记。Reference is now made to Figures 14 and 15, which illustrate one embodiment of an impactor catheter based on a pneumatic energy source on the proximal side of the catheter and a weight-pull impact mechanism on the distal portion. Again, like elements are labeled like above.
现参考图14,图14示出导管的远端。导管通过引线11被递送入瓣膜。外护套(轴)12缩回以暴露稳定器臂50,稳定器臂50从外轴12向外扩张。(稳定器臂50从图15中所示的稳定器轴51延伸。)然后,导管被推向远侧,直到稳定器臂50与瓣膜瓣叶的主动脉方面足够接触。然后,冲击器前进通过瓣膜的中心(通过引线11)进入LVOT(左心室流出道)。Reference is now made to Figure 14, which shows the distal end of the catheter. A catheter is delivered into the valve through a guide wire 11 . The outer sheath (shaft) 12 is retracted to expose the stabilizer arms 50 which expand outwardly from the outer shaft 12 . (The stabilizer arm 50 extends from the stabilizer shaft 51 shown in Figure 15.) The catheter is then advanced distally until the stabilizer arm 50 is in sufficient contact with the aortic aspect of the valve leaflet. The impactor is then advanced through the center of the valve (via lead 11) into the LVOT (left ventricular outflow tract).
该实施例包括冲击器臂52,冲击器臂优选地但不是必须地由镍钛诺管裁剪出并预成形成通常半打开。冲击器臂52的远端(或一个共同的远端)固定(例如焊接)到内管(轴)54,内管54在冲击器管(轴)18内自由前后移动。当内管54在导管的近侧上由操作者朝向近侧牵引时,冲击器臂52向外侧移延伸,增大冲击器直径。当内管54被推向远侧时,冲击器臂52闭合或减小其直径。改变内管54相对于冲击器轴18的相对位置允许操作者在每次治疗瓣膜时在手术期间设定最优的冲击器直径。此外,这允许操作者选择钙化的瓣叶上被冲击的区域。该实施例中所示的另一选项是能够与稳定器(或与稳定器一起)和瓣膜瓣叶相对地转动冲击器,以冲击瓣膜瓣叶上的其它(或不同的)区域。在设定冲击器臂直径和角度位置中,现可由用户锁定这些设定(通过锁定内管54在导管的控制侧处在操作者手中的位置)。现在,冲击器被轻轻地牵引直到冲击器与瓣叶的心室侧足够接触且同时被锁定在纵向位置中。This embodiment includes an impactor arm 52 which is preferably, but not necessarily, cut from a Nitinol tube and pre-formed generally half-open. The distal ends (or a common distal end) of the impactor arms 52 are fixed (eg, welded) to an inner tube (shaft) 54 which is free to move back and forth within the impactor tube (shaft) 18 . As the inner tube 54 is drawn proximally by the operator on the proximal side of the catheter, the impactor arms 52 extend laterally, increasing the impactor diameter. As inner tube 54 is pushed distally, impactor arm 52 closes or reduces its diameter. Changing the relative position of the inner tube 54 with respect to the impactor shaft 18 allows the operator to set the optimal impactor diameter during the procedure each time the valve is treated. Furthermore, this allows the operator to select the area on the calcified leaflet to be impacted. Another option shown in this embodiment is to be able to rotate the impactor relative to (or with) the stabilizer and the valve leaflets to impact other (or different) areas on the valve leaflets. In setting the impactor arm diameter and angular position, these settings can now be locked by the user (by locking the position of the inner tube 54 in the operator's hand on the control side of the catheter). Now, the impactor is gently pulled until the impactor is in sufficient contact with the ventricular side of the leaflet and at the same time is locked in the longitudinal position.
借助于重物牵引轴56能够如上所述朝向近侧牵引重物24。The weight 24 can be pulled proximally by means of the weight pull shaft 56 as described above.
现参考图15,图15示出图14中所描述的冲击器导管的近侧。气动能量源58(其用作偏压器件)连接到加压气源(工作室壁入口、压缩器、气囊等)。气动能量源58的本体优选地连接到稳定器轴51,以反作用于对位于导管的远侧部上的瓣膜瓣叶施加的冲击。如图14所述,由用户设置并锁定内轴54相对于冲击器轴18的纵向位置以及冲击器轴18的纵向和角度位置。重物/牵引轴56现被推到最远端位置并然后连接到活塞62和近侧质量块64。活塞62布置成在主气缸66内滑动,主气缸66容纳气动阀68并通过空气入口72对来自空气容器70的空气开放。当气动阀68由操作者打开时,空气容器70中的加压空气通过空气入口72释放到主气缸66,由此在一定的距离上快速加速活塞62和近侧质量块64。在对连接到位于导管的末端处的远侧重物24的重物轴/牵引轴56进行牵引的同时,活塞62和近侧质量块64获得相对高能量(动量)。在达到一定的行进距离时,远侧重物24击打冲击器臂52,冲击器臂52然后将能量传递给瓣膜钙化物以形成破碎。使用重物/牵引机构允许通过柔性导管传递高冲击能量。Reference is now made to FIG. 15 , which shows the proximal side of the impactor catheter depicted in FIG. 14 . A source of pneumatic energy 58 (which acts as a biasing device) is connected to a source of pressurized air (working chamber wall inlet, compressor, air bladder, etc.). The body of the pneumatic energy source 58 is preferably connected to the stabilizer shaft 51 to react the impact applied to the valve leaflets on the distal portion of the catheter. As shown in FIG. 14 , the longitudinal position of the inner shaft 54 relative to the striker shaft 18 as well as the longitudinal and angular positions of the striker shaft 18 are set and locked by the user. The weight/pull shaft 56 is now pushed to the most distal position and is then connected to the piston 62 and the proximal mass 64 . Piston 62 is arranged to slide within a master cylinder 66 which houses a pneumatic valve 68 and is open to air from an air container 70 through an air inlet 72 . When pneumatic valve 68 is opened by the operator, pressurized air in air container 70 is released to master cylinder 66 through air inlet 72, thereby rapidly accelerating piston 62 and proximal mass 64 over a distance. Piston 62 and proximal mass 64 acquire relatively high energy (momentum) while pulling on weight/pull shaft 56 connected to distal weight 24 at the tip of the catheter. Upon reaching a certain distance of travel, the distal weight 24 strikes the impactor arm 52, which then transfers energy to the valve calcifications to form a fragment. Use of a weight/pull mechanism allows high impact energy to be delivered through the flexible conduit.
现参考图16A-16D,其示出根据本发明的另一非限制实施例的冲击器器件100。器件100包括外护套101,在外护套101中布置一个或更多个定位元件102和一个或更多个(径向地)振动(冲击)元件103。器件100具有末端104,末端104允许器件通过引线11被引导穿过心室。图16A至16D示出外护套101的逐渐收回和定位元件102的打开。图16D示出振动元件103的径向打开。Reference is now made to FIGS. 16A-16D , which illustrate an impactor device 100 according to another non-limiting embodiment of the present invention. The device 100 comprises an outer sheath 101 in which one or more positioning elements 102 and one or more (radially) vibrating (shocking) elements 103 are arranged. The device 100 has a tip 104 that allows the device to be guided through the ventricle by the lead 11 . 16A to 16D illustrate the gradual retraction of the outer sheath 101 and the opening of the positioning element 102 . FIG. 16D shows the radial opening of the vibrating element 103 .
振动机构是主动器件,其能够被制作成以由操作者确定或由制造商预设定的频率和振幅在径向方向上移动进出。该内振动机构进行:在定位元件已经被早先定位的同时,振动机构抵靠在天生的瓣叶的内侧上振动,从而在指定位置处施加力;并提供对所述力的阻力。所获得的作用可改变瓣叶内的钙化物结构。The vibration mechanism is an active device that can be made to move in and out in a radial direction at a frequency and amplitude determined by the operator or preset by the manufacturer. The inner vibratory mechanism vibrates against the inner side of the native leaflet, while the positioning element has been positioned earlier, thereby exerting a force at the designated location, and provides resistance to said force. The effect obtained changes the structure of the calcifications within the valve leaflets.
振动机构可构造成具有围绕其外周的轴向切开的狭缝的管。如果管被压缩使得其端部朝向彼此移动,周向切开的狭缝之间的材料将径向向外延伸(元件103)。The vibration mechanism may be configured as a tube with an axially cut slit around its outer circumference. If the tube is compressed such that its ends move towards each other, the material between the circumferentially cut slits will extend radially outward (element 103).
现参考图17,图17示出器件100的远端,定位元件102和振动元件103都分别在其打开位置。注意,振动元件103可以围绕器件100的外周均匀分布或不均匀分布。Referring now to FIG. 17, FIG. 17 shows the distal end of the device 100 with the positioning member 102 and the vibrating member 103 respectively in their open positions. Note that vibrating elements 103 may be distributed uniformly or non-uniformly around the periphery of device 100 .
图18A和18B示出有疾病三尖瓣心脏瓣膜,具有钙化损害的有疾病瓣叶。瓣膜的开口(图18B)被钙化物不利地影响。Figures 18A and 18B show a diseased tricuspid heart valve, diseased leaflets with calcified lesions. The opening of the valve (Fig. 18B) was adversely affected by calcifications.
现参考图19A-19I,图19A-19I示出使用该器件的对于有疾病瓣膜的治疗。引线11被引入动脉并前进直到引线的远端穿过瓣膜瓣叶。在主动脉瓣膜情形中,引线11将前进直到引线的远端位于左心室内。器件100通过引线11前进,直到器件的远端位于瓣膜环带处或靠近瓣膜环带。外护套101被部分地抽出,暴露定位机构,定位机构的元件102径向向外延伸。器件100沿远端方向(在主动脉瓣膜情形中,朝向左心室)移动,从而定位元件102抵靠瓣叶的下游表面与主动脉壁之间的袋搁置。可以轻轻地转动器件100以便于元件102的适当定位。Reference is now made to FIGS. 19A-19I , which illustrate treatment of a diseased valve using the device. Lead wire 11 is introduced into the artery and advanced until the distal end of the wire passes through the valve leaflets. In the case of an aortic valve, the lead 11 will be advanced until the distal end of the lead is within the left ventricle. The device 100 is advanced through the lead 11 until the distal end of the device is at or near the valve annulus. The outer sheath 101 is partially withdrawn, exposing the positioning mechanism, the element 102 of which extends radially outwards. The device 100 is moved in the distal direction (in the case of the aortic valve, towards the left ventricle) so that the positioning element 102 rests against the pocket between the downstream surface of the leaflet and the aortic wall. Device 100 may be turned slightly to facilitate proper positioning of element 102 .
一旦就位,振动机构主动地径向扩张,从而振动元件103抵靠瓣膜瓣叶的内部或下游表面搁置。抵靠瓣叶预拉伸振动元件103是可能的,从而抵靠瓣叶组织保持拉伸,瓣叶组织被夹在定位元件102与振动元件103之间。Once in position, the vibrating mechanism actively expands radially so that the vibrating element 103 rests against the inner or downstream surface of the valve leaflets. It is possible to pre-tension the vibrating element 103 against the leaflet so as to remain stretched against the leaflet tissue, which is sandwiched between the positioning element 102 and the vibrating element 103 .
操作者现在可开始元件103的振动运动,从而反复性的力被施加到瓣叶的内表面,由此实现瓣叶组织中形成的钙化物的结构的改变。The operator can now initiate an oscillating movement of the element 103 whereby repetitive forces are applied to the inner surface of the leaflet thereby effecting a structural change of the calcifications formed in the leaflet tissue.
现参考图20,图20示出定位元件102,该定位元件102具有与其连接从而捕获可作为处理的一部分产生的任何碎片的网105。该网可围绕定位元件102分布,并可由大范围的合适材料来制成。Reference is now made to Figure 20 which shows a positioning element 102 having a mesh 105 attached thereto to capture any debris that may be generated as part of the process. The mesh can be distributed around the positioning element 102 and can be made from a wide range of suitable materials.
现参考图21A和21B,图21A和21B示出另一可能的实施例,其中,定位元件102是可充气的垫或气囊。气囊通常填充有诸如生理盐水的液体,并可提供抵抗由振动机构产生的力所需的反作用力。气囊以不阻挡冠状动脉开口的方式被充气。Reference is now made to Figures 21A and 21B, which illustrate another possible embodiment in which the positioning element 102 is an inflatable cushion or bladder. The bladder is usually filled with a fluid such as saline and provides the counterforce needed to resist the force generated by the vibrating mechanism. The balloon is inflated in such a way that it does not block the opening of the coronary arteries.
图22A示出纵向切开穿过主动脉壁,具有在每个瓣叶的中心线处由冲击器(其例如具有三个冲击臂)形成的破碎线。类似地,可预设定或实现任何数目和样式的破碎。图22B是在靠近其中心线产生单个破碎之后的典型瓣叶的X光照片。Figure 22A shows a longitudinal incision through the aortic wall with a fracture line formed by an impactor (eg, having three impact arms) at the centerline of each leaflet. Similarly, any number and pattern of fragmentation may be preset or implemented. Figure 22B is a radiograph of a typical valve leaflet after a single fragmentation near its centerline.
本发明的范围包括上文所述的特征的组合和子组合以及本领域技术人员在阅读上述描述后将发生的并且不在现有技术中的其变型和变体。The scope of the present invention includes combinations and subcombinations of the features described above as well as modifications and variations thereof which would occur to a person skilled in the art after reading the above description and which are not in the prior art.
Claims (14)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26702909P | 2009-12-05 | 2009-12-05 | |
| US61/267,029 | 2009-12-05 | ||
| US35661710P | 2010-06-20 | 2010-06-20 | |
| US61/356,617 | 2010-06-20 | ||
| PCT/US2010/058810 WO2011069025A1 (en) | 2009-12-05 | 2010-12-03 | Fracturing calcifications in heart valves |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102791207A CN102791207A (en) | 2012-11-21 |
| CN102791207B true CN102791207B (en) | 2015-09-09 |
Family
ID=43828294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201080062697.5A Active CN102791207B (en) | 2009-12-05 | 2010-12-03 | Make the calcified material in cardiac valve broken |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US9554816B2 (en) |
| EP (1) | EP2506781B1 (en) |
| CN (1) | CN102791207B (en) |
| WO (1) | WO2011069025A1 (en) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1049450A (en) * | 1996-07-31 | 1998-02-20 | Kyocera Corp | Recovery method when an error occurs in the remote monitoring system |
| US11589880B2 (en) | 2007-12-20 | 2023-02-28 | Angiodynamics, Inc. | System and methods for removing undesirable material within a circulatory system utilizing during a surgical procedure |
| US20170136158A1 (en) | 2015-10-16 | 2017-05-18 | Angiodynamics, Inc. | Systems and Methods for Removing Undesirable Material Within a Circulatory System |
| US10517617B2 (en) | 2007-12-20 | 2019-12-31 | Angiodynamics, Inc. | Systems and methods for removing undesirable material within a circulatory system utilizing a balloon catheter |
| US20100036294A1 (en) | 2008-05-07 | 2010-02-11 | Robert Mantell | Radially-Firing Electrohydraulic Lithotripsy Probe |
| WO2009152352A2 (en) | 2008-06-13 | 2009-12-17 | Aspen Medtech, Inc. | Shockwave balloon catheter system |
| US9044618B2 (en) | 2008-11-05 | 2015-06-02 | Shockwave Medical, Inc. | Shockwave valvuloplasty catheter system |
| US20180214165A1 (en) * | 2017-01-30 | 2018-08-02 | Pi-Cardia Ltd. | Fracturing calcifications in heart valves |
| US9055964B2 (en) * | 2011-03-15 | 2015-06-16 | Angio Dynamics, Inc. | Device and method for removing material from a hollow anatomical structure |
| US12245788B2 (en) | 2011-03-15 | 2025-03-11 | Angiodynamics, Inc. | Device and method for removing material from a hollow anatomical structure |
| US8574247B2 (en) | 2011-11-08 | 2013-11-05 | Shockwave Medical, Inc. | Shock wave valvuloplasty device with moveable shock wave generator |
| CN104023656B (en) * | 2011-12-05 | 2017-02-15 | Pi-R-方形有限公司 | Calcium deposits in broken heart valves |
| EP2833825B1 (en) * | 2012-04-06 | 2019-02-20 | Pi-R-Squared Ltd. | Device for treatment of the aortic valve |
| AU2013300176B2 (en) | 2012-08-06 | 2017-08-17 | Shockwave Medical, Inc. | Low profile electrodes for an angioplasty shock wave catheter |
| CA2881184C (en) | 2012-08-06 | 2019-06-04 | Shockwave Medical, Inc. | Shockwave catheter |
| US9554815B2 (en) * | 2012-08-08 | 2017-01-31 | Shockwave Medical, Inc. | Shockwave valvuloplasty with multiple balloons |
| US9333000B2 (en) | 2012-09-13 | 2016-05-10 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
| US9522012B2 (en) | 2012-09-13 | 2016-12-20 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
| DE102012021547A1 (en) * | 2012-11-02 | 2014-05-08 | Johnson & Johnson Medical Gmbh | Surgical implant |
| EP2941210B1 (en) | 2013-01-07 | 2016-11-16 | Pi-Cardia Ltd. | Stabilizer assembly for fracturing calcifications in heart valves |
| CA3075128C (en) | 2013-03-11 | 2022-07-19 | Northgate Technologies Inc. | Unfocused electrohydraulic lithotripter |
| US10368852B2 (en) | 2013-06-26 | 2019-08-06 | Strait Access Technologies Holdings (Pty) Ltd | Orientation device for use in mitral valve repair |
| FR3021859A1 (en) * | 2014-06-05 | 2015-12-11 | Bernard Pain | DEVICE FOR CUTTING AND REMOVING CALCIFIED TISSUES FROM A HEART VALVE |
| US20160135828A1 (en) * | 2014-11-14 | 2016-05-19 | Shockwave Medical, Inc. | Shock wave valvuloplasty device and methods |
| WO2016110760A1 (en) * | 2015-01-05 | 2016-07-14 | Strait Access Technologies Holdings (Pty) Ltd | Heart valve leaflet capture device |
| RU2708222C2 (en) * | 2015-01-05 | 2019-12-04 | Стрейт Эксесс Текнолоджиз Холдингз (Пти) Лтд | Heart valve leaflet capture device |
| WO2017087195A1 (en) | 2015-11-18 | 2017-05-26 | Shockwave Medical, Inc. | Shock wave electrodes |
| WO2017168345A1 (en) * | 2016-03-31 | 2017-10-05 | Pi-Cardia Ltd. | Remodeling of calcified aortic valve leaflets |
| AU2017339980B2 (en) | 2016-10-06 | 2022-08-18 | Shockwave Medical, Inc. | Aortic leaflet repair using shock wave applicators |
| US20180098777A1 (en) * | 2016-10-11 | 2018-04-12 | Shlomo Gabbay | Devices and Methods for Improving Transcatheter Aortic Valve Implantation |
| US20220096105A1 (en) * | 2016-10-26 | 2022-03-31 | Pi-Cardia Ltd. | Catheter based device for the treatment of calcified valve leaflet |
| US10357264B2 (en) | 2016-12-06 | 2019-07-23 | Shockwave Medical, Inc. | Shock wave balloon catheter with insertable electrodes |
| US10966737B2 (en) | 2017-06-19 | 2021-04-06 | Shockwave Medical, Inc. | Device and method for generating forward directed shock waves |
| WO2019053538A1 (en) * | 2017-09-12 | 2019-03-21 | Aorticlab Sarl | Transcatheter device for the treatment of calcified heart valve leaflets |
| US10624658B2 (en) * | 2017-10-03 | 2020-04-21 | Pi-Cardia Ltd. | Impactor and stabilizer for fracturing calcifications in heart valves |
| US10709462B2 (en) | 2017-11-17 | 2020-07-14 | Shockwave Medical, Inc. | Low profile electrodes for a shock wave catheter |
| US11596769B2 (en) | 2018-01-16 | 2023-03-07 | Daniel Ezra Walzman | Bypass catheter |
| US11006996B2 (en) * | 2018-01-16 | 2021-05-18 | Daniel Ezra Walzman | Torus balloon with energy emitters for intravascular lithotripsy |
| US11596438B2 (en) | 2018-01-16 | 2023-03-07 | Daniel Ezra Walzman | Bypass catheter |
| US10799674B2 (en) | 2018-01-16 | 2020-10-13 | Daniel Ezra Walzman | Bypass catheter |
| EP3809988B1 (en) | 2018-06-21 | 2023-06-07 | Shockwave Medical, Inc. | System for treating occlusions in body lumens |
| EP4512350A3 (en) | 2019-09-24 | 2025-05-07 | Shockwave Medical, Inc. | Low profile electrodes for a shock wave catheter |
| WO2021061451A1 (en) | 2019-09-24 | 2021-04-01 | Shockwave Medical, Inc. | Lesion crossing shock wave catheter |
| WO2021061523A1 (en) | 2019-09-24 | 2021-04-01 | Shockwave Medical, Inc. | System for treating thrombus in body lumens |
| US11648020B2 (en) | 2020-02-07 | 2023-05-16 | Angiodynamics, Inc. | Device and method for manual aspiration and removal of an undesirable material |
| US12011184B2 (en) | 2020-02-10 | 2024-06-18 | Elixir Medical Corporation | Methods and apparatus for plaque disruption |
| CN115768363A (en) * | 2020-07-07 | 2023-03-07 | 皮-卡尔迪亚有限公司 | Heart valve treatment member with variable orientation |
| US11992232B2 (en) | 2020-10-27 | 2024-05-28 | Shockwave Medical, Inc. | System for treating thrombus in body lumens |
| CA3157546C (en) | 2020-12-18 | 2023-06-13 | Vesalius Cardiovascular Inc. | Device for stabilizing catheters and method of use thereof |
| US12023098B2 (en) | 2021-10-05 | 2024-07-02 | Shockwave Medical, Inc. | Lesion crossing shock wave catheter |
| JP2025527519A (en) * | 2022-07-08 | 2025-08-22 | エドワーズ ライフサイエンシーズ コーポレイション | Systems and methods for treating calcified heart valves |
| EP4385428A1 (en) * | 2022-12-12 | 2024-06-19 | Aorticlab Srl | Transfemoral system for the localized treatment of aortic valve stenosis |
| CN116115296A (en) * | 2023-02-03 | 2023-05-16 | 深圳市赛禾医疗技术有限公司 | Valve balloon catheter |
| US12290268B2 (en) | 2023-03-31 | 2025-05-06 | Shockwave Medical, Inc. | Shockwave catheters for treating rhinosinusitis |
| US12035932B1 (en) | 2023-04-21 | 2024-07-16 | Shockwave Medical, Inc. | Intravascular lithotripsy catheter with slotted emitter bands |
| US12220141B2 (en) | 2023-06-29 | 2025-02-11 | Shockwave Medical, Inc. | Catheter system with independently controllable bubble and arc generation |
| WO2025027430A1 (en) * | 2023-07-30 | 2025-02-06 | Pi-Cardia Ltd. | Centering stabilizer for heart valve device |
| US12426904B2 (en) | 2023-11-17 | 2025-09-30 | Shockwave Medical, Inc. | Intravascular lithotripsy catheter with oscillating impactor |
| US12402899B2 (en) | 2023-11-30 | 2025-09-02 | Shockwave Medical, Inc. | Systems, devices, and methods for generating shock waves in a forward direction |
| US12433620B2 (en) | 2024-02-23 | 2025-10-07 | Shockwave Medical, Inc. | Locus emitter shock wave catheter devices with increased longevity and higher sonic output |
| US12178458B1 (en) | 2024-05-16 | 2024-12-31 | Shockwave Medical, Inc. | Guidewireless shock wave catheters |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6387071B1 (en) * | 1998-07-15 | 2002-05-14 | Corazon Technologies, Inc. | Methods and devices for reducing the mineral content of vascular calcified lesions |
| CN101076290A (en) * | 2004-12-09 | 2007-11-21 | 铸造品公司 | Aortic valve repair |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5176688A (en) * | 1991-07-17 | 1993-01-05 | Perinchery Narayan | Stone extractor and method |
| US5449363A (en) * | 1994-05-06 | 1995-09-12 | Browne Medical Systems, Inc. | Endoscopic lithotripsy system |
| US20040267306A1 (en) * | 2003-04-11 | 2004-12-30 | Velocimed, L.L.C. | Closure devices, related delivery methods, and related methods of use |
| US7537592B2 (en) * | 2003-06-20 | 2009-05-26 | Plc Medical Systems, Inc. | Endovascular tissue removal device |
| US7744620B2 (en) * | 2003-07-18 | 2010-06-29 | Intervalve, Inc. | Valvuloplasty catheter |
| US20060100553A1 (en) * | 2004-10-25 | 2006-05-11 | Lodin David W | Heart valve decalcification method and apparatus |
| US8402974B2 (en) * | 2006-05-30 | 2013-03-26 | Coherex Medical, Inc. | Methods, systems, and devices for sensing, measuring, and controlling closure of a patent foramen ovale |
| US8092470B2 (en) * | 2006-06-08 | 2012-01-10 | Olympus Medical Systems Corp. | Calculus crushing apparatus and medical procedure using endoscope |
| CN101505668A (en) * | 2006-06-20 | 2009-08-12 | 奥尔特克斯公司 | Prosthetic valve implant site preparation techniques |
| US7815676B2 (en) * | 2006-07-07 | 2010-10-19 | The Cleveland Clinic Foundation | Apparatus and method for assisting in the removal of a cardiac valve |
| WO2008150796A1 (en) * | 2007-05-29 | 2008-12-11 | Kassab Ghassan S | Devices, systems, and methods for valve removal |
| JP5588978B2 (en) | 2008-07-27 | 2014-09-10 | ピー・アイ−アール スクエアド エル・ティー・ディー | Fracture of calcification in heart valve |
| CN102186427B (en) * | 2008-09-22 | 2013-12-18 | 浩特斯博尔技术公司 | flow recovery system |
| US20120116289A1 (en) * | 2010-11-09 | 2012-05-10 | Daniel Hawkins | Shockwave valvuloplasty device with guidewire and debris basket |
-
2010
- 2010-12-03 EP EP10803420.8A patent/EP2506781B1/en active Active
- 2010-12-03 US US13/514,090 patent/US9554816B2/en active Active
- 2010-12-03 CN CN201080062697.5A patent/CN102791207B/en active Active
- 2010-12-03 WO PCT/US2010/058810 patent/WO2011069025A1/en active Application Filing
-
2021
- 2021-09-02 US US17/464,890 patent/US11690637B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6387071B1 (en) * | 1998-07-15 | 2002-05-14 | Corazon Technologies, Inc. | Methods and devices for reducing the mineral content of vascular calcified lesions |
| CN101076290A (en) * | 2004-12-09 | 2007-11-21 | 铸造品公司 | Aortic valve repair |
Also Published As
| Publication number | Publication date |
|---|---|
| US9554816B2 (en) | 2017-01-31 |
| EP2506781B1 (en) | 2018-03-21 |
| US20120253358A1 (en) | 2012-10-04 |
| WO2011069025A1 (en) | 2011-06-09 |
| EP2506781A1 (en) | 2012-10-10 |
| US11690637B2 (en) | 2023-07-04 |
| CN102791207A (en) | 2012-11-21 |
| US20210393281A1 (en) | 2021-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102791207B (en) | Make the calcified material in cardiac valve broken | |
| CN104023656B (en) | Calcium deposits in broken heart valves | |
| EP2326264B1 (en) | Fracturing calcifications in heart valves | |
| US7255706B2 (en) | Apparatus and method for cutting a heart valve | |
| US6746463B1 (en) | Device for percutaneous cutting and dilating a stenosis of the aortic valve | |
| JP6546906B2 (en) | Transapical implant systems, implants and methods | |
| EP2699302B1 (en) | Devices and systems for accurate positioning of a prosthetic valve | |
| JP2012245389A (en) | Prosthetic valve implant site preparation technique | |
| CN108834399A (en) | The prosthetic heart valve and delivery apparatus of belt supporting frame with parcel | |
| WO2011083460A2 (en) | Device system and method for reshaping tissue openings | |
| US20180214165A1 (en) | Fracturing calcifications in heart valves | |
| CN118215449A (en) | Heart valve prosthesis delivery systems and methods of use | |
| JP6930997B2 (en) | Remodeling of calcified aortic valve leaflets | |
| US20040193204A1 (en) | Percutaneous transluminal endarterectomy | |
| US20230346401A1 (en) | Fracturing calcifications in heart valves | |
| EP3359063B1 (en) | Impactor for fracturing calcifications in heart valves | |
| WO2025217385A1 (en) | Tissue perforation apparatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |